Ranbaxy posts loss in Sept quarter due to forex charges
REUTERS - Drugmaker Ranbaxy Laboratories (RANB.NS) posted a loss for the second straight quarter, hurt by foreign exchange charges and a one-time write-off related to one of its plants under an import ban by the U.S. health regulator.
Net loss in July-September was 4.5 billion rupees from a profit of 7.5 billion rupees a year earlier, it said. Ranbaxy is 63.5 percent owned by Japan's Daiichi Sankyo Co (4568.T).
The company incurred a forex charge of 3.6 billion rupees in the latest quarter, while the year-ago results included a forex gain of 3.93 billion rupees.
Sales rose 3 percent to 27.5 billion rupees during the quarter.
The U.S. Food and Drug Administration imposed an import alert last month on Ranbaxy's factory in Mohali in northern India, saying the plant had not met "good manufacturing practices".
All three Ranbaxy plants in India dedicated to the U.S. market, which accounts for more than 40 percent of its sales, have now been barred from shipping to the United States.
The company had pleaded guilty in May to U.S. felony charges related to drug safety and agreed to a record $500 million in fines. After falling more than 40 percent in the months afterwards, the share price had started to inch back up.
(Reporting by Aradhana Aravindan and Swati Pandey in MUMBAI; Editing by Prateek Chatterjee)
- Tweet this
- Share this
- Digg this
- UPDATE 2-U.S. fast-food workers rally for higher minimum wage
- South Africa, world mourn "giant for justice" Mandela
- Springsteen's handwritten 'Born to Run' draft fetches $197,000
- UPDATE 5-GM to drop Chevy brand in Europe to focus on Opel
- UPDATE 4-Child killed in Idaho school bus accident, 4 more hurt
South African anti-apartheid hero Nelson Mandela died aged 95 at his Johannesburg home on Thursday after a prolonged lung infection, plunging his nation and the world into mourning for a man hailed by global leaders as a moral giant. Article | Obituary